EPISODE · Jan 20, 2026 · 1 MIN
Promising Prostate Cancer Therapy
from TheBrief.Health · host TheBrief.Health
The theranostic agent 67Cu-SAR-bisPSMA advances in trials, offering a promising, targeted treatment option for metastatic castration-resistant prostate cancer with limited existing therapies.
What this episode covers
The theranostic agent 67Cu-SAR-bisPSMA advances in trials, offering a promising, targeted treatment option for metastatic castration-resistant prostate cancer with limited existing therapies.
NOW PLAYING
Promising Prostate Cancer Therapy
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m